MedStar Health Research Institute, Hyattsville, Maryland.
MedStar National Rehabilitation Hospital, Washington, DC.
Top Spinal Cord Inj Rehabil. 2023 Winter;29(1):82-93. doi: 10.46292/sci22-00095. Epub 2023 Feb 15.
To explore the association between dipstick results and urinary symptoms.
This was a prospective 12-month observational study of real-time self-administered urine dipstick results and symptoms in a community setting that included 52 spinal cord injury/disease (SCI/D) participants with neurogenic lower urinary tract dysfunction (NLUTD) who use an indwelling catheter. Symptoms were collected using the Urinary Symptom Questionnaire for Neurogenic Bladder-Indwelling Catheter (USQNB-IDC). The USQNB-IDC includes actionable (A), bladder (B1), urine quality (B2), and other (C) symptoms; analyses focused on A, B1, and B2 symptoms. Dipstick results include nitrite (NIT +/-), and leukocyte esterase (LE; negative, trace, small, moderate, or large). Dipstick outcomes were defined as strong positive (LE = moderate/large and NIT+), inflammation positive (LE = moderate/large and NIT-), negative (LE = negative/trace and NIT-), and indeterminate (all others).
Nitrite positive dipsticks and moderate or large LE positive dipsticks were each observed in over 50% of the sample in every week. Strong positive dipstick results were observed in 35% to 60% of participants in every week. A, B1, or B2 symptoms co-occurred less than 50% of the time with strong positive dipsticks, but they also co-occurred with negative dipsticks. Participants were asymptomatic with a strong positive dipstick an average of 30.2% of the weeks. On average, 73% of the time a person had a negative dipstick, they also had no key symptoms (95% CI, .597-.865).
No association was observed between A, B1, and B2 symptoms and positive dipstick. A negative dipstick with the absence of key symptoms may better support clinical decision-making.
探讨尿试纸结果与尿路症状之间的关系。
这是一项在社区环境中进行的为期 12 个月的实时自我管理尿试纸结果和症状的前瞻性观察研究,共纳入 52 例患有神经源性下尿路功能障碍(NLUTD)并使用留置导尿管的脊髓损伤/疾病(SCI/D)患者。使用神经源性膀胱留置导尿管尿症状问卷(USQNB-IDC)收集症状。USQNB-IDC 包括可行动(A)、膀胱(B1)、尿液质量(B2)和其他(C)症状;分析重点关注 A、B1 和 B2 症状。尿试纸结果包括亚硝酸盐(NIT +/-)和白细胞酯酶(LE;阴性、痕量、少量、中量或大量)。尿试纸结果定义为强阳性(LE = 中量/大量和 NIT+)、炎症阳性(LE = 中量/大量和 NIT-)、阴性(LE = 阴性/痕量和 NIT-)和不确定(其他所有情况)。
每周超过 50%的样本中观察到亚硝酸盐阳性尿试纸和 LE 阳性中量或大量的尿试纸。每周有 35%至 60%的参与者出现强阳性尿试纸结果。强阳性尿试纸结果与 A、B1 或 B2 症状同时出现的频率低于 50%,但也与阴性尿试纸同时出现。强阳性尿试纸结果时参与者平均有 30.2%的周无症状。平均而言,73%的时间里,当一个人出现阴性尿试纸时,他们也没有关键症状(95%CI,.597-.865)。
未观察到 A、B1 和 B2 症状与阳性尿试纸之间存在关联。在不存在关键症状的情况下出现阴性尿试纸可能更能支持临床决策。